Cannabis Stocks Slide After U.S. Moves to Tighten Hemp Rules in Shutdown Deal -- WSJ

Dow Jones11-13

By Anvee Bhutani

Cannabis-linked shares fell Wednesday after the U.S. government funding bill to end the shutdown included language tightening rules on hemp-derived THC products.

Shares of cannabis company Tilray Brands $(TLRY)$ have dropped about 5%, while Green Thumb Industries (GTBIF) slipped 2.3%. Marijuana-linked exchange-traded funds are also trading lower, with the AdvisorShares Pure U.S. Cannabis ETF $(MSOS)$ down about 3% and the Cambria Cannabis ETF (TOKE) off 2.2%.

Trulieve Cannabis Corp. (TCNNF) shares fell around 4.5% Tuesday but rebounded some Wednesday.

Tilray criticized the hemp provision, calling it a "misguided" step that risks pushing consumers toward unregulated products. "Prohibition and overly restrictive measures do not work," the company said in a statement, urging Congress to adopt "smart, forward-looking regulation."

Read more about what this means for the hemp market.

This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).

(END) Dow Jones Newswires

November 12, 2025 15:52 ET (20:52 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment